We've detected an Ad Blocker in your browser.

Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.

Menu

14–15 October 2022


3 daily broadcasts:

Bangkok - 14:20 ICT | Paris - 14:20 CEST | Rio - 14:20 BRT



REGISTER FREE

LOG IN

Please enter your email address

Having trouble logging in? Please email info@radcliffe-group.com

validation result

Please choose one of the options shown

Please enter your registration lead id

Please enter your registration session id

Please enter your successful log-in count

feed resp param id

Please choose one of the options shown

A global virtual event dedicated to the latest heart failure treatment strategies to support better patient outcomes

Overview

Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology are delighted to introduce e-SPACE Heart Failure 2022 to be held 14–15 October.

e-SPACE Heart Failure 2022 will deliver best-in-class free-to-access virtual education. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 will both optimise geographical reach whilst delivering both global and regional insight.

A thoughtfully curated programme will support the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice, as well as aiding the discovery of the latest information on patient profiling in heart failure for tailoring medical therapy.

Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) will lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.

This year’s e-SPACE Heart Failure will, for the first time, bring together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

Underpinned by this combined expertise in educational content and delivery, and led by an international faculty of global standing, e-SPACE Heart Failure 2022 promises to be the widest reaching and most engaging to date.

Register now to join us.

REGISTER FREE NOW

REGISTER NOW

Register Now

This live conference starts in:

DAYS
:

HOURS
:

MINS
:

SECS

Course Leadership

Prof Stefan Anker
Prof Stefan Anker

CHAIR
Charité Campus Virchow-Klinikum, Berlin, DE

Prof Stefan Anker studied medicine at Charité Medical School of Humboldt-University Berlin, Germany from 1987 to 1993. He went on to complete his PhD at the National Heart and Lung Institute of Imperial College London, United Kingdom, in 1998. Since then, he has had teaching appointments in several countries including the UK, Germany, Australia and Italy.
He has worked as a Junior Professor and then as Professor for Charité Campus Virchow-Klinikum since 2002. He is a member of and serves on the Boards of several academic organizations, including the Board of the Heart Failure Association of the European Society of Cardiology and the Editorial Board of the Journal of Cachexia, Sarcopenia and Muscle (SCWD). He is also a member of the German Centre for Cardiovascular Research (DZHK).

More info

Less info

Dr Javed Butler
Dr Javed Butler

CO-CHAIR
Baylor Scott and White Research Institute, Texas, US

Dr Javed Butler is Professor and Chair of the Department of Medicine at University of Mississippi Medical Center in Jackson Mississippi, and also Patrick H Lehan Chair of Cardiovascular Research. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He has authored more than 900 peer-reviewed publications. Previously, he was Director of the Division of Cardiovascular Medicine and Co-director of the Heart Institute at State University of New York (SUNY) Stony Brook University.

More info

Less info

Prof Andrew Coats
Prof Andrew Coats

CHAIR
University of Warwick, Coventry, UK

Prof Andrew Coats is President of the Heart Failure Association and Professor of Cardiology, University of Warwick, Coventry, UK. He is an Australian-British academic cardiologist and inventor with a main interest of heart failure.
From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine of the University of Sydney. Prof Coats is Editor-in-Chief of the Cardiac Failure Review editorial board.

More info

Less info

Dr Shelley Zieroth
Dr Shelley Zieroth

CHAIR
University of Manitoba, Manitoba, CA

Dr Shelley Zieroth is at SBH Heart Failure and Transplant Clinics and serves as Head of the Medical Heart Failure Program, WRHA Cardiac Sciences Program, and as Associate Professor of the Section of Cardiology at the University of Manitoba, Canada. Dr Zieroth attended medical school at the University of Manitoba, where she went on to train in internal medicine and cardiology. She completed her postdoctoral clinical fellowship, specializing in advanced heart failure and cardiac transplant, at Toronto General Hospital. She has lectured internationally on the subject of heart failure. Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.

More info

Less info

Faculty

Prof Magdy Abdelhamid
Prof Magdy Abdelhamid

Kasr Al-Ainy School of Medicine, Cairo, EG

Prof William Abraham
Prof William Abraham

Ohio State University College of Medicine. Ohio, US

Dr Marianna Adamo
Dr Marianna Adamo

University of Brescia, Brescia, IT

Dr John Atherton
Dr John Atherton

Royal Brisbane and Women’s Hospital, Brisbane, AU

Dr Cecilia Bahit
Dr Cecilia Bahit

INECO Neurociencias Oroño, Santa Fe, AR

Prof George L. Bakris
Prof George L. Bakris

University of Chicago Medicine, Illinois, US

Prof Johann Bauersachs
Prof Johann Bauersachs

Hannover Medical School, Hannover, DE

Dr Biykem Bozkurt
Dr Biykem Bozkurt

Baylor College of Medicine, Texas, US

Prof Antonio Ceriello
Prof Antonio Ceriello

IRCCS MultiMedica, Milan, IT

Prof Ovidiu Chioncel
Prof Ovidiu Chioncel

University of Medicine Carol Davila, Bucharest, RO

Dr Vijay Chopra
Dr Vijay Chopra

Max Super Specialty Hospital, New Delhi, IN

Prof John Cleland
Prof John Cleland

University of Glasgow, Glasgow, UK

Prof Marisa G. Crespo-Leiro
Prof Marisa G. Crespo-Leiro

University of A Coruña, A Coruña, ES

Dr Justin Ezekowitz
Dr Justin Ezekowitz

University of Alberta, Alberta, CA

Prof Gerasimos Filippatos
Prof Gerasimos Filippatos

National and Kapodistrian University of Athens, Athens, GR

Dr Marat Fudim
Dr Marat Fudim

Duke University, North Carolina, US

Dr Sivadasanpillai Harikrishnan
Dr Sivadasanpillai Harikrishnan

Sree Chitra Institute, Trivandrum, IN

Prof Ewa Jankowska
Prof Ewa Jankowska

Wrocław Medical University, Wrocław, PL

Dr Tammy Lyn Kindel
Dr Tammy Lyn Kindel

Medical College of Wisconsin, Wisconsin, US

Prof Friedrich Köhler
Prof Friedrich Köhler

Charité Campus Mitte, Berlin, DE

Prof Mitja Lainscak
Prof Mitja Lainscak

University of Ljubljana, Ljubljana, SI

Prof Béla Merkely
Prof Béla Merkely

Semmelweis University Heart and Vascular Center, Budapest, HU

Prof Marco Metra
Prof Marco Metra

University of Brescia, Brescia, IT

Dr Alanna A. Morris
Dr Alanna A. Morris

Emory University School of Medicine, Georgia, US

Dr Milton Packer
Dr Milton Packer

Baylor University Medical Center, Texas, US

Prof Mark Petrie
Prof Mark Petrie

University of Glasgow, Glasgow, UK

Dr Ileana Piña
Dr Ileana Piña

Wayne State University, Michigan, US

Prof Piotr Ponikowski
Prof Piotr Ponikowski

Wrocław Medical University, Wrocław, PL

Prof Giuseppe Rosano
Prof Giuseppe Rosano

St George's University of London, London, UK

Prof Clara Ines Saldarriaga
Prof Clara Ines Saldarriaga

Cardiovascular Clinic Santa Maria, Medellin, CO

Dr Gianluigi Savarese
Dr Gianluigi Savarese

Karolinska Institute, Stockholm, SE

Prof Petar Seferović
Prof Petar Seferović

Belgrade University, Belgrade, RS

Prof Horst Sievert
Prof Horst Sievert

CardioVascular Center Frankfurt, Frankfurt, DE

Prof Philippe Gabriel Steg
Prof Philippe Gabriel Steg

Hopital Bichat, Paris, FR

Prof Gregg Stone
Prof Gregg Stone

Icahn School of Medicine at Mount Sinai, New York, US

Prof Thomas Thum
Prof Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies, Hannover, DE

Prof Hiroyuki Tsutsui
Prof Hiroyuki Tsutsui

Kyushu University, Fukuoka, JP

Dr Katherine Tuttle
Dr Katherine Tuttle

University of Washington, Washington, US

Dr Harriette Van Spall
Dr Harriette Van Spall

McMaster University, Hamilton, CA

Dr Subodh Verma
Dr Subodh Verma

St. Michael's Hospital, Toronto, CA

Prof Stephan von Haehling
Prof Stephan von Haehling

University Medicine Göttingen, Göttingen, DE

Prof Mehmet Birhan Yilmaz
Prof Mehmet Birhan Yilmaz

Dokuz Eylul University, Izmir, TR

Dr Faiez Zannad
Dr Faiez Zannad

Academic Hospital (CHU), Nancy, FR

Prof Yuhui Zhang
Prof Yuhui Zhang

Fuwai Hospital, Beijing, CN

Register now

Programme

(Please note this programme is subject to change)

Friday, October 14, 2022 (Day 1)
Local time
Zone 1 (Bangkok – UTC +7)
Zone 2 (Paris – UTC +2)
Zone 3 (Rio – UTC -3)
14:20–14:50
Meet the expert / case discussion
Meet the expert / case discussion
Meet the expert / case discussion
15:00–16:00
Plenary session 1:
Implementing the 4 foundational therapies in clinical practice
Chairs: John Atherton and Marianna Adamo
• At discharge: Piotr Ponikowski
• In outpatients clinic: Mark Petrie
• At home: Gianluigi Savarese
• Can biomarkers help here?:
• Panel discussion
Plenary session 3:
Using SGLT2 in your patients: practical considerations
Chairs: Philippe Gabriel Steg and Shelley Zieroth
• When to use them: Milton Packer
• Managing the side effects: Cecilia Bahit
• When not to use them: Subodh Verma
• Panel discussion
Plenary session 5:
Managing side effects of HF drugs
Chair: Prof Mitja Lainscak
• Abnormal eGFR levels: Faiez Zannad
• Infection: Justin Ezekowitz
• Drug-to-drug interactions: Ileana Piña
• Hypotension: Harriette Van Spall
• Panel discussion
16:10–16:50
Industry-sponsored session
Industry-sponsored session
Industry-sponsored session
17:00–18:00
Plenary session 2:
Managing your HF patients with comorbidities (part 1)
Chair: Yuhui Zhang
• Coronary artery disease & angina: Giuseppe Rosano
• Hypertension: Vijay Chopra
• Ventricular arrhythmia: Béla Merkely
• Panel discussion
Plenary session 4:
Managing your HF patients with comorbidities (part 2)
• Iron deficiency: Ewa Jankowska
• Cardiorenal disease: George L. Bakris
• Frailty: Stephan von Haehling
• Hyperkalemia: Javed Butler
• Panel discussion
Plenary session 6:
How to manage the obese patient with HF
Chair: Antonio Ceriello
• GLP1 agonist: Stefan Anker
• Bariatric surgery: Tammy Lyn Kindel
• Exercise: Andrew Coats
• Panel discussion
18:10–18:40
Meet the expert / case discussion
Meet the expert / case discussion
Meet the expert / case discussion
Saturday, October 15, 2022 (Day 2)
Local time
Zone 1 (Bangkok – UTC +7)
Zone 2 (Paris – UTC +2)
Zone 3 (Rio – UTC -3)
14:20–14:50
Meet the expert / case discussion
Meet the expert / case discussion
Meet the expert / case discussion
15:00–16:00
Plenary session 7:
New technologies to manage your patients
Chairs: Vijay Chopra and Stefan Anker
• Classic telemedicine: Friedrich Köhler
• Panel discussion
Plenary session 9:
Comparing European and US recent guidelines
Chairs: Stefan Anker
• HFpEF: Marco Metra
• HFrEF: Biykem Bozkurt
• Acute HF: Gerasimos Filippatos
• Unknown epidemiology of heart failure - Why we need a new universal definition: John Cleland
• Panel discussion
Plenary session 11:
Managing the HF patient with valvular heart disease
• Update on Mitraclip: Greg Stone
• The place of Carillon: Horst Sievert
• Panel discussion
16:10–16:50
Industry-sponsored session
Industry-sponsored session
Industry-sponsored session
17:00–18:00
Plenary session 8:
New technologies to treat your patients
• CCM in clinical practice: Marat Fudim
• Barostimulation: Johann Bauersachs
• IntraAtrial shunt devices: William Abraham
• New miRNA drugs: Thomas Thum
• Panel discussion
Plenary session 10:
How to implement these GLS in ambulatory patients around the world
Chair: Katherine Tuttle and Mehmet Birhan Yilmaz
• Europe: Petar Seferović
• India: Sivadasanpillai Harikrishnan
• China: Yuhui Zhang
• Middle East: Magdy Abdelhamid
• South America: Clara Ines Saldarriaga
• Japan: Hiroyuki Tsutsui
• Panel discussion
Plenary session 12:
Managing the patient with worsening and advanced HF
Chairs: Marisa G. Crespo-Leiro and Ovidiu Chioncel
• Definition of WHF and disease burden: Alanna A. Morris
• Patients with low blood pressure: Gerasimos Filippatos
• Panel discussion

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts

If you’re interested in becoming an educational partner or sponsor at this event, please contact sales@radcliffe-group.com

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit www.tmacademy.org.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community.

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking

Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.

Please contact events@radcliffe-group.com should you have any queries.